Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Kentarou Takei"'
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 8, p 4494 (2024)
Information regarding Klebsiella aerogenes haboring carbapenemase in Japan is limited. A comprehensive nationwide survey was conducted from September 2014 to December 2022, and 67 non-duplicate strains of carbapenem-resistant K. aerogenes were isolat
Externí odkaz:
https://doaj.org/article/7bd4ef3e3dd7425fb47a471d00a3f300
Publikováno v:
Pathogens, Vol 12, Iss 10, p 1246 (2023)
In Japan, nationwide epidemiological surveys on carbapenem-resistant Enterobacterales (CREs), including comprehensive information, are scarce, with most data available only through public reports. This study analyzed data on the Enterobacterales fami
Externí odkaz:
https://doaj.org/article/12a5358be8a142fbbaccb06b10cb0188
Publikováno v:
Clinical Infection in Practice, Vol 16, Iss , Pp 100158- (2022)
Background: TAFRO syndrome, a subtype of idiopathic multicentric Castleman disease, is an acute or subacute systemic inflammatory disease that causes fever, generalized oedema (pleural effusion or ascites), and thrombocytopenia and is associated with
Externí odkaz:
https://doaj.org/article/f3b8814838334265bd37cd6e352705c5
Autor:
Kentarou Takei, Hajime Kanamori, Asami Nakayama, Mikiko Chiba, Yumiko Takei, Issei Seike, Chiho Kitamura, Hiroaki Baba, Kengo Oshima, Koichi Tokuda
Publikováno v:
Antibiotics, Vol 12, Iss 7, p 1146 (2023)
Metallo-beta-lactamases (MBLs) are enzymes that break down carbapenem antibiotics, leading to carbapenem-resistant organisms. Carbapenemase-resistant Enterobacterales (CRE) is one of them. Outbreaks of CRE infection can occur in healthcare facilities
Externí odkaz:
https://doaj.org/article/0787cbaf4c3d4970ad100aa49c4a8f28
Autor:
Yudai Iwasaki, Yusuke Takei, Mitsuhiro Yamada, Shigekazu Sugino, Koji Saito, Tetsuji Aoyagi, Kengo Oshima, Hajime Kanamori, Hiroaki Baba, Kentarou Takei, Koichi Tokuda, Eichi N. Kodama, Tetsuro Kamo, Tadashi Kamio, Takehiko Kasai, Satoru Ogawa, Masanori Yamauchi
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 10, p 3460 (2023)
Coronavirus disease 2019 (COVID-19) is associated with coagulopathy. However, the underlying mechanisms are not completely understood. We evaluated the association between COVID-19 coagulopathy and extracellular vesicle (EV) levels. We hypothesized t
Externí odkaz:
https://doaj.org/article/29c3ca44c835442faf0910290b3933d0
Autor:
Manami Suzuki, Kentarou Takei, Hisatoshi Sugiura, Kei Sato, Tsutomu Tamada, Koji Murakami, Hirohito Sano, Naoki Tode, Yoko Tsukita, Daisuke Narita, Nozomu Kimura, Shuichiro Matsumoto, Yoshinao Ono, Chikashi Iwasaki, Hatsumi Sugiyama, Sho Kakuto, Shuichi Konno, Hajime Kanamori, Hiroaki Baba, Kengo Oshima, Koichi Tokuda
Publikováno v:
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
Rational Corticosteroid therapy plays a key role in the treatment of COVID-19 patients with respiratory failure. However, a rebound phenomenon after steroid cessation rarely occurs. Here, we investigated the clinical features of patients with rebound
Externí odkaz:
https://doaj.org/article/6088d4c0a91548638130220f7dc5d3ac
Clinical and Epidemiological Characteristics of Persistent Bacteremia: A Decadal Observational Study
Autor:
Shiori Kitaya, Hajime Kanamori, Hiroaki Baba, Kengo Oshima, Kentarou Takei, Issei Seike, Makoto Katsumi, Yukio Katori, Koichi Tokuda
Publikováno v:
Pathogens, Vol 12, Iss 2, p 212 (2023)
Background: Bloodstream infections (BSIs), including persistent bacteremia (PB), are a leading source of morbidity and mortality globally. PB has a higher mortality rate than non- PB, but the clinical aspects of PB in terms of the causative pathogens
Externí odkaz:
https://doaj.org/article/8cf0083898f54062bb4308fd746417bb
Autor:
Tetsuji Aoyagi, Yukio Sato, Hiroaki Baba, Takuya Shiga, Issei Seike, Ikumi Niitsuma Sugaya, Kentarou Takei, Yudai Iwasaki, Kengo Oshima, Hajime Kanamori, Makiko Yoshida, Koji Saito, Koichi Tokuda, Mitsuo Kaku
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Acute respiratory distress syndrome (ARDS) is the leading cause of mortality in hospitalized patients with coronavirus disease 2019 (COVID-19) because of limited effective therapies. During infection, the accumulation and activation of macrophages an
Externí odkaz:
https://doaj.org/article/ceca40d59979478fab1633a4ea6a09cc
Autor:
Shiori Kitaya, Hiroaki Baba, Michiko Okamoto, Masahiro Sakamoto, Asami Nakayama, Yumiko Takei, Issei Seike, Kentarou Takei, Kengo Oshima, Koichi Tokuda, Takuya Shiga, Hajime Kanamori
Publikováno v:
Journal of Travel Medicine.
Highlights Cargo ships are at risk of disease outbreaks like Legionella and SARS-CoV-2 due to their cramped and shared conditions. A case of medical evacuation due to co-infection of Legionella pneumophila with SARS-CoV-2 highlights the need for inte
Autor:
Koji Murakami, Hirohito Sano, Naoki Tode, Yoko Tsukita, Kei Sato, Daisuke Narita, Nozomu Kimura, Shuichiro Matsumoto, Yoshinao Ono, Chikashi Iwasaki, Hatsumi Sugiyama, Manami Suzuki, Sho Kakuto, Shuichi Konno, Hajime Kanamori, Hiroaki Baba, Kengo Oshima, Kentarou Takei, Koichi Tokuda, Tsutomu Tamada, Hisatoshi Sugiura
Publikováno v:
BMJ Open Respiratory Research. 9:e001332
RationalCorticosteroid therapy plays a key role in the treatment of COVID-19 patients with respiratory failure. However, a rebound phenomenon after steroid cessation rarely occurs. Here, we investigated the clinical features of patients with rebound